Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M.D.R. Vidal Tocino"'
Autor:
E.M. Sánchez Tapia, M. Muñoz García, C.A. Rodríguez Sáchez, B. Barrios Collado, A. Olivares Hernandez, L. Figuero Pérez, J.M. Perez Garcia, J. Claros Ampuero, A. Amores Martin, E. Escalera Martín, J.J. Cruz Hernandez, R.A. Escala Cornejo, R. González Sarmiento, E. Terán Brage, M.D.R. Vidal Tocino, Á. López Gutiérrez, T. Martín Gómez
Publikováno v:
Annals of Oncology. 31:S336-S337
Autor:
M.D.R. Vidal Tocino, A. Olivares Hernandez, E. Escalera Martín, Juan J. Cruz-Hernández, C.A. Rodríguez Sánchez, J. Claros Ampuero, A. Amores Martin, L. Figuero Pérez, J.P. Miramontes González, R. Gonzalez Sarmiento, R.A. Escala Cornejo
Publikováno v:
Annals of Oncology. 30:xi23-xi24
Background Type 1 diabetes mellitus (T1D) as an immune-mediated effect of immunotherapy-based oncology treatments is observed in 0.5-5% of the patients. Prevention of these symptoms is based on the determination of the basal sugar levels on an empty
Autor:
I. Toribio García, B. Barrios Collado, Á. López Gutiérrez, R.A. Escala Cornejo, A. Olivares Hernandez, C.A. Rodríguez Sáchez, J.J. Cruz Hernandez, M.D.R. Vidal Tocino, L. Figuero Pérez, E. Terán Brage, Jose Pablo Miramontes-Gonzalez, E. Escalera Martín, J. Claros Ampuero, A. Amores Martin
Publikováno v:
Annals of Oncology. 31:S1064
Autor:
M.D.R. Vidal Tocino, Capucine Baldini, Antoine Hollebecque, Edouard Auclin, P. Martin Romano, Rocio Garcia-Carbonero, F. Longo Muñoz, Benjamin Besse, Laura Mezquita, Christophe Massard, Y. El Dakdouki, P. Vuagnat, Andreea Varga, J. Adeva Alfonso
Publikováno v:
Annals of Oncology. 30:xi20
Background Microsatellite instability high (MSI-H) is an approved tissue-agnostic predictive biomarker of benefit to immune checkpoint inhibitors (ICI). However not all patients (pts) respond to ICI and additional biomarker of response in this popula